Grief Screening vs Clinical Assessment
Author: Angela Bogdanova · Published: October 9, 2026 · Editorial Policy
Research cluster: Grief, Loss & Bereavement · Written by Artificial Sapiens
Grief screening and clinical assessment serve different purposes in bereavement care. A screening questionnaire can identify symptoms that deserve closer attention. A clinical assessment establishes what those experiences mean for a particular person, whether a diagnosable condition may be present, what other explanations need consideration, and which kind of support fits the situation. A positive grief screen is an invitation to a thoughtful conversation, not a diagnosis of prolonged grief disorder.
This distinction matters because yearning, disbelief, sadness, anger, disrupted sleep, and changes in concentration can be part of ordinary grief. The 2024 assessment and reporting guidelines by Stroebe, Schut, and Eisma explain why treating questionnaire thresholds as confirmed diagnoses can exaggerate estimates of prolonged grief disorder (PGD). This guide explains the major screening tools, their strengths and limits, how clinicians assess grief, and what people can do with their results.
For related context, see Prolonged Grief Disorder: Symptoms and Diagnosis.
What Is Grief Screening?
Grief screening is a brief, standardized way of asking about experiences after a death. It may be completed on paper, online, during a primary care visit, through a mental health service, or as part of research. Some questionnaires measure general grief intensity; others were designed specifically to identify symptoms associated with prolonged grief disorder. The person responding usually rates the frequency, severity, or impact of particular experiences over a specified period.
A screening score summarizes answers according to a measure's rules. When it exceeds a researched threshold, it may indicate that further evaluation would be worthwhile. A screen does not independently establish whether the full DSM-5-TR or ICD-11 diagnostic requirements are satisfied, nor whether the person needs grief-focused psychotherapy. Some tools are designed to track change over time even when no diagnosis is suspected. A systematic review of grief assessment instruments documented considerable variation among measures and the criteria they covered.
What screening can tell you
Screening can make persistent yearning, emotional pain, avoidance, difficulty reengaging with life, or perceived impairment easier to notice and discuss. It can help a service decide whom to invite for a more detailed consultation, give clinicians a structured baseline, and help researchers describe symptom patterns. Repeating the same validated measure can sometimes inform follow-up, provided the score is interpreted with attention to life events, language, the questionnaire's timeframe, and ordinary measurement error.
A score is one piece of evidence about responses to particular questions on a particular day. Its meaning changes with the time since the death, the context of the loss, the purpose for which the scale was validated, and the population in which it is used. No grief score measures a person's love for the deceased, the importance of their relationship, or the legitimacy of their mourning.
What screening cannot establish
Screening alone cannot determine that someone has a mental disorder, whether a response exceeds cultural expectations, whether a person has concurrent depression or PTSD, or whether difficulties are better explained by another condition. It does not establish the full timeline of symptoms, the nature of impairment, or suicide risk with sufficient detail for clinical decisions. A low score also cannot prove that a person has no need for help.
The 2024 Harvard Review of Psychiatry assessment guidelines distinguish questionnaire-defined probable cases from diagnoses confirmed by appropriate clinical evaluation. This difference should be preserved in health information, clinical notes, and research reporting.
Screening vs Clinical Assessment: The Main Differences
Purpose and outcome
Screening asks whether certain grief-related symptoms may warrant further inquiry. It generally produces a symptom score, severity profile, or designation such as screen-positive or probable PGD. Clinical assessment asks what the symptoms signify and what help is appropriate. It may result in a formulation of normal or intense bereavement, a diagnosis when criteria are met, identification of another or additional condition, a care plan, or a decision to monitor without assigning a diagnosis.
Method and depth
Screening is usually brief and structured, often based on self-report. Clinical assessment takes more time and includes conversation, contextual inquiry, observation, and, when appropriate, a trained clinician's structured diagnostic interview. The clinician clarifies ambiguous answers and examines the relationship between symptoms, recent experiences, functioning, and personal circumstances.
Diagnostic certainty and next steps
A screening instrument's validation describes how reliably it measures a construct and, when studied, how well it identifies probable cases in particular samples. Diagnostic conclusions require the applicable full criteria, duration, impairment or distress, cultural considerations, and differential diagnosis. Clinical recommendations may involve compassionate support, primary care, grief counseling, specialized therapy, assessment for other conditions, or urgent safety care.
The 2021 clinical overview by Szuhany and colleagues describes both questionnaire measures and clinician-administered interviews while emphasizing the need to assess psychiatric history, mental state, functioning, and suicidal thoughts when clinically indicated.
Normal Grief, Bereavement, Mourning, and Prolonged Grief Disorder
Bereavement refers to the experience or state of having lost someone through death. Grief describes responses to that loss, which may include yearning, sorrow, numbness, anxiety, anger, guilt, relief, loneliness, physical sensations, and shifts in meaning or identity. Mourning describes expressions, practices, and processes of responding to a death, shaped by family, community, religion, and culture. None follows a universal emotional sequence.
Ordinary grief can be very intense. A person may have strong waves of emotion, find particular dates especially difficult, feel close to the deceased through memories, or struggle to work or sleep during the early period after a death. These experiences need humane attention and may merit support even without a diagnosable condition. The relevant clinical question is how symptoms develop and affect the person's life in context.
Prolonged grief disorder is a recognized condition associated with persistent longing or preoccupation with the deceased, additional grief-related difficulties, clinically significant distress or impairment, and a symptom pattern extending beyond expected cultural, social, or religious norms. Diagnostic requirements differ between the DSM-5-TR and ICD-11. A 2025 Lancet review00354-X) summarizes the distinct symptom pattern and associated functional difficulties. The diagnostic framework is explained in depth in our linked PGD overview.
DSM-5-TR: Age-specific minimum duration
For DSM-5-TR prolonged grief disorder, at least 12 months must have passed since the death for adults, or at least six months for children and adolescents. The criteria also require characteristic separation-related symptoms, associated symptoms and frequency requirements, clinically significant distress or impairment, and a response exceeding cultural, social, or religious norms. An American Psychiatric Association DSM-5-TR update from September 2024 specifically clarifies the clinical significance and cultural context requirements.
Elapsed time is necessary to establish eligibility for the DSM-5-TR diagnosis, but time alone never establishes it. At 12 months, a person with powerful memories or sadness may be experiencing a grief response entirely consistent with their circumstances. Severe distress before that point can still deserve a clinical assessment and appropriate care.
ICD-11: Duration and cultural context
ICD-11 recognizes prolonged grief disorder with persistent and pervasive grief responses following a death, core yearning or preoccupation, accompanying emotional pain, marked functional problems, and a response that persists for an atypically long period relative to expected social, cultural, or religious norms. Its description uses a minimum period of more than six months after the loss, with clinical interpretation of context. This differs from the DSM-5-TR adult threshold of at least 12 months and its more explicitly enumerated symptom requirements.
Clinicians need to state which system they are using. A screening instrument that approximates one diagnostic system cannot automatically deliver a diagnosis under the other. The World Health Organization's 2024 ICD-11 clinical diagnostic manual is the authoritative clinical framework for ICD-11, while the American Psychiatric Association provides the DSM-5-TR framework.
Common Grief Screening Questionnaires
There is no single universal grief test that is best for every person or clinical setting. Measures differ in what they ask, whether they correspond to current criteria, the language and population in which they were evaluated, and how a score should be interpreted. The following tools illustrate the main options; their mention here does not endorse self-diagnosis.
Brief Grief Questionnaire (BGQ)
The Brief Grief Questionnaire is a short five-item measure developed to screen for problematic grief reactions. It can be practical when time is limited or when a service wants to ask whether grief-specific follow-up may be useful. Its brevity is also a limitation: it cannot cover the full DSM-5-TR and ICD-11 diagnostic requirements or the context of an individual's mourning. Historical cutoff values appear in the clinical assessment review, but they should not be transferred automatically to unvalidated populations or treated as diagnostic boundaries.
Prolonged Grief Disorder-13-Revised (PG-13-R)
The PG-13-R is a commonly studied self-report instrument developed to assess symptoms corresponding to the DSM-5-TR conception of PGD. In a multisite validation study, Prigerson and colleagues found support for its reliability and validity in bereaved adult samples. The authors evaluated a symptom-score threshold in those research samples. That result is evidence about a scale's performance within particular study designs; it does not remove the need for a clinician to establish other diagnostic requirements and rule out alternative explanations.
The PG-13-R should also be distinguished from older PG-13 versions. Versions of a scale can differ in symptom content and alignment with criteria. Anyone interpreting results should verify the exact version, scoring instructions, timeframe, language, and evidence supporting its intended use.
Traumatic Grief Inventory–Self Report Plus (TGI-SR+)
The 22-item TGI-SR+ was designed to cover symptom sets related to DSM-5 persistent complex bereavement disorder as well as DSM-5-TR and ICD-11 prolonged grief disorder. A 2022 validation study found promising psychometric properties in Dutch samples with different bereavement experiences, and subsequent studies have examined translations and additional groups.
The instrument's broader coverage is valuable when researchers compare diagnostic systems. It also makes accurate administration important: a total score and a criteria-based algorithm answer different questions. Study-specific thresholds vary by version, population, and target criteria. A validated symptom scale remains a self-report instrument rather than a substitute for a comprehensive interview.
Inventory of Complicated Grief (ICG)
The Inventory of Complicated Grief is a widely used 19-item measure of grief-related difficulties. It was prominent in research before PGD acquired its current DSM-5-TR and ICD-11 classifications. It can still be useful for measuring symptoms and comparing historical research, but its symptom composition and cutoff rules do not automatically establish either current diagnosis.
This distinction is particularly important when a web-based test labels an ICG score a definitive test for prolonged grief disorder. A systematic review of 11 assessment instruments found that criterion coverage and diagnostic algorithms differed substantially across measures.
International Prolonged Grief Disorder Scale (IPGDS)
The IPGDS was developed specifically around ICD-11 prolonged grief concepts and includes cultural material intended to capture context-specific expressions. Its initial Chinese and German-speaking validation research provides preliminary support for the measurement approach. This is a useful advance for cross-cultural research, but validation in two linguistic contexts does not justify assuming equal measurement performance everywhere.
Aarhus Prolonged Grief Disorder Scales
The Aarhus PGD Scale and a later brief version are newer tools explicitly addressing ICD-11 and DSM-5-TR criteria. A 2025 study of the brief Aarhus scale described promising psychometric properties and relationships with a structured clinical interview. Its evidence base is developing and should be interpreted with attention to relatively small and selected validation samples. Aarhus University also provides professional assessment resources, including questionnaires and interview materials.
Why Grief Screening Cutoff Scores Are Not Universal
A cutoff is a decision rule chosen to separate higher from lower likelihood of a target condition within a particular research or service context. It may optimize sensitivity, specificity, or another statistical property in one study, but the same numeric score can perform differently in a different population. A cutoff designed for adults may be unsuitable for children; one validated after traumatic loss cannot be assumed equivalent after all types of loss; and translation may change how individual questions are understood.
Sensitivity describes how many people with the target condition a screening rule identifies. Specificity describes how many people without the condition the rule correctly identifies. A test with imperfect sensitivity can miss someone who would benefit from assessment, and a test with imperfect specificity can refer people who will not meet diagnostic criteria. Both outcomes have practical consequences, and neither can be understood from a score alone.
Positive predictive value adds another essential consideration: how many screen-positive people actually meet the condition when properly assessed? That value depends partly on how common the condition is in the population being screened. A threshold validated in a specialty grief clinic might produce a different percentage of confirmed diagnoses when applied to bereaved people in a general community. Stroebe and colleagues identify this as a central limitation in claims based solely on questionnaire-defined cases.
Why an online grief test may mislead
Some websites use an unnamed questionnaire, provide no citation for the version or cutoff, fail to ask when the death occurred, or imply that any intense grief is disordered. Others use the term complicated grief while silently assuming that an older research cutoff equates to current PGD criteria. A scientifically meaningful tool should identify its source, intended age group, symptom timeframe, scoring interpretation, and limits.
A test may still be a useful starting point for reflection. The responsible way to use it is to take your responses, concerns, and questions to a qualified professional who can interpret them in context. Immediate help should be based on safety needs, not on the number generated by a website.
What Happens During a Clinical Grief Assessment?
A careful clinical assessment is a collaborative discussion about the loss, the grief response, daily life, relevant health history, and what the person hopes to gain from support. Professionals may use a structured interview, symptom scales, and established diagnostic criteria, but their central task is to develop an accurate understanding of the individual.
1. Understanding the death and the relationship
A clinician may ask whom the person lost, their relationship, when the death happened, whether it was anticipated or sudden, and what support was available. They may explore other simultaneous stressors, caregiving demands, previous losses, funeral or mourning practices, financial changes, and the person's own understanding of the death. Questions should be asked with sensitivity, especially where the death involved violence, suicide, overdose, stigma, war, or uncertain circumstances.
2. Exploring the central grief experiences
Assessment explores yearning or longing, preoccupation with the deceased, emotional pain, difficulty accepting the reality of the death, disruption of identity, avoidance of reminders, loneliness, numbness, and problems reconnecting with life. The interviewer clarifies frequency, duration, intensity, changes over time, and whether descriptions mean the same thing to clinician and patient.
For a child, the questions must be developmentally appropriate. Adults and children may express the same underlying experience differently; children's grief may appear in play, separation concerns, behavior, or shifting attention. The purpose is to understand a pattern rather than count isolated emotions.
3. Examining distress and everyday functioning
The interviewer explores work, school, sleep, relationships, childcare, self-care, health, and the capacity to pursue ordinary activities. A person may be distressed yet functioning in important areas, or outwardly functioning while struggling severely. The clinical formulation considers both.
Impairment also needs contextual interpretation. Temporary time away from work for funerals, disrupted routines following displacement, or a difficult anniversary may be understandable consequences of bereavement. Ongoing, clinically significant difficulty, especially when coupled with the relevant PGD symptom pattern and duration, calls for closer inquiry. DSM-5-TR's updated differential guidance emphasizes clinical significance and cultural norms.
4. Evaluating the timeline
The clinician establishes the date of death and the trajectory of grief symptoms, including fluctuations, periods of improvement, new stressors, and persistent difficulties. This helps determine whether duration requirements can be met and distinguishes expected waves of grief from a more enduring pattern.
Neither the one-year anniversary nor the six-month mark is an automatic date for diagnosis. Relevant care can begin before diagnostic time thresholds are reached, and people can experience significant grief for years without fulfilling the criteria for a disorder.
5. Assessing mental and physical health
A grief assessment can include questions about mood, traumatic stress, anxiety, sleep, substance use, physical illness, medications, prior psychiatric history, and current treatment. A clinician may consider a separate evaluation for depression, PTSD, adjustment disorder, or medical conditions if indicated. The purpose is to identify the full set of needs; grief-specific symptoms and other disorders can coexist.
6. Evaluating safety and immediate needs
When someone expresses a wish to die, thoughts of self-harm, feelings of unbearable hopelessness, or difficulty staying safe, the clinician should ask directly about thoughts, intent, plans, access to means, protective supports, and immediate safety. These questions require a real conversation, not inference from a grief questionnaire. Immediate safety needs take priority over whether the minimum period for a PGD diagnosis has elapsed.
7. Explaining findings and agreeing on next steps
A meaningful assessment concludes with an understandable explanation. The clinician should distinguish symptoms and risks from a confirmed diagnosis, explain any remaining uncertainty, discuss how cultural and family context informed the interpretation, and agree on a follow-up or care plan. A person may need grief information, practical support, counseling, specialized treatment, evaluation of another condition, or planned monitoring. A written summary can help when the discussion feels overwhelming.
Structured Clinical Interviews for Prolonged Grief Disorder
Structured and semi-structured interviews support consistent exploration of relevant symptoms, duration, impairment, and differential diagnoses. They can help trained clinicians avoid relying only on intuitive impressions or self-report scores. However, using a structured format does not make the interview infallible; interviewer training, translation, context, and population validation remain important.
Older approaches include the Structured Clinical Interview for Complicated Grief, which was developed before the present manuals fully converged on their current PGD formulations. The newer Aarhus Prolonged Grief Disorder Interview (A-PGDi) was designed to address both ICD-11 and DSM-5-TR. A 2025 validation study involving 124 bereaved adults reported evidence of content and criterion validity and of reliability while noting important limitations, including a relatively small, predominantly female, self-selected sample.
A structured interview helps implement diagnostic criteria; a full clinical assessment additionally considers comorbidity, safety, circumstances of the loss, health, and goals for care. University-hosted Aarhus interview and training materials are intended for qualified professional use.
Differential Diagnosis: Grief, Depression, PTSD, and Adjustment Disorder
Grief and major depressive disorder
Grief often centers on the death and the missing relationship, with reactions that rise and fall in response to memories, occasions, or reminders. Major depressive disorder may involve more pervasive low mood or loss of interest, self-critical thoughts, hopelessness, and other symptoms across areas of life. There is substantial overlap, and a grieving person can also develop depression. The distinction depends on a full evaluation, not on whether someone reports sadness or loss of pleasure.
A grief questionnaire is built to measure grief-related symptoms, not to decide whether criteria for major depression are present. Clinicians may therefore supplement grief assessment with a separate depression evaluation when indicated. The clinical review of PGD and co-occurring psychiatric conditions explains why such differential assessment is necessary.
Grief and posttraumatic stress disorder
After a sudden, violent, or horrifying death, grief and trauma-related symptoms may coexist. PTSD is associated with exposure to trauma and characteristic patterns such as intrusive reexperiencing, avoidance, changes in mood or cognition, and arousal-related symptoms. Prolonged grief disorder centers more specifically on the enduring absence of the deceased, separation-related longing, and the difficulty of adapting to that loss.
Someone may avoid a place because it evokes the death scene, because it brings overwhelming longing, or for several reasons simultaneously. A clinical interview clarifies the meanings of symptoms. A systematic review of grief measurement after traumatic loss found wide variation in measures and highlighted the need for clearer alignment with current criteria.
Grief and adjustment disorder
Adjustment disorder involves clinically significant emotional or behavioral symptoms in response to a stressor according to the applicable diagnostic system. Bereavement can occur alongside multiple stressors, and a clinician may consider adjustment-related difficulties when the presentation does not match PGD or another condition. The appropriate conclusion depends on symptom pattern, timing, impairment, contextual expectations, and the specific diagnostic framework being applied.
Anxiety, substance use, and physical illness
Anxiety symptoms, increased alcohol use, sleep disturbance, chronic pain, and physical illness may complicate bereavement. Some symptoms overlap with grief, some are independent, and some intensify each other. Screening for grief is a starting point for identifying needs, not a complete mental or physical health evaluation. Medical concerns require appropriate medical assessment.
Assessment for Children and Adolescents
Grief assessment in young people requires developmentally suitable language, attention to changing understanding of death, and awareness that symptoms may appear differently at school, with caregivers, and in private. Parents or teachers can provide useful information, but a young person's own account remains important. A child should not be labeled on the basis of an adult questionnaire or a single caregiver's score.
The DSM-5-TR minimum duration for PGD is six months for children and adolescents, rather than the 12-month adult requirement. Nonetheless, serious distress or safety concerns warrant support whenever they arise. Clinical evaluation considers attachment, developmental stage, bereavement circumstances, family coping, school functioning, and other potential disorders.
A systematic review of instruments for bereaved children and adolescents identified numerous measures but also highlighted gaps in rigorous validation. The Traumatic Grief Inventory–Kids–Clinician-Administered development study incorporated feedback from bereaved youth and clinicians. More recent research continues to assess its measurement properties, and sample-specific thresholds should not be generalized beyond their supporting evidence.
Culture, Religion, Language, and the Meaning of a Score
The social environment shapes how grief is expressed and what is considered an expected response. Rituals, continued bonds with the deceased, periods of mourning, public displays of emotion, private reserve, spiritual beliefs, and community responsibilities vary. An assessment must understand these practices from the bereaved person's perspective rather than treat unfamiliar customs as symptoms.
Translation alone does not establish measurement equivalence. Questions about longing, identity, emotional pain, or the deceased may carry different meanings across languages. A culturally appropriate evaluation may require a validated translated instrument, interpretation, and discussion of family or community expectations. The IPGDS development study demonstrates how culture-specific items can be included while underscoring the need for broader validation.
Migration, discrimination, unresolved legal issues, economic insecurity, displacement, war, and barriers to customary mourning may affect functioning and grief. A clinical conclusion should account for these conditions. Cultural responsiveness is an integral part of diagnostic accuracy.
When Should Someone Seek an Assessment?
An assessment can be useful when grief is causing serious or persistent difficulties in sleep, work, school, relationships, self-care, or the ability to participate in daily life; when a person feels stuck in overwhelming separation distress; when intrusive traumatic memories or depressive symptoms coexist; when substances are being used to cope; or simply when the person wants professional help understanding what is happening.
There is no requirement to wait six or twelve months to ask for support. An earlier visit may lead to monitoring, counseling, trauma-informed care, evaluation of depression or PTSD, or practical assistance, while a PGD diagnosis under the applicable criteria may be premature. People whose grief remains intense many years after a death may also find an assessment useful without prejudging its outcome.
What if the screening result is positive?
Ask which instrument and version were used, what population and criteria its threshold was validated against, and what follow-up the clinician recommends. Bring the score if you have it, along with a timeline of the loss, changes in daily functioning, any current medications or treatment, and your most important concerns. You can ask whether a structured grief interview or another assessment is appropriate.
What if the result is negative but the person is struggling?
Describe the difficulties directly. Screening thresholds miss some clinically important presentations, and people may need support for depression, PTSD, anxiety, physical problems, family disruption, or intense non-disordered grief. Access to care should follow the person's needs as well as standardized data.
What if the result is unclear?
Ask for a plain-language explanation of what was measured and what remains uncertain. A clinician may repeat the tool later, obtain a fuller history, consult a specialist, or use another validated measure. Assessment can be an ongoing process when grief experiences and circumstances evolve.
What Support Can Follow a Clinical Assessment?
Some people benefit most from reassurance, social connection, bereavement resources, help with practical tasks, and space for their own mourning practices. Others may want grief counseling focused on coping and adjustment. When PGD is diagnosed and causes significant impairment, a clinician may recommend an evidence-based, grief-focused psychotherapy. Treatment decisions also depend on access, preference, co-occurring conditions, and safety.
Screening tools are not treatments, and evidence supporting a questionnaire's validity does not prove that every person who screens positive needs specialized psychotherapy. Similarly, the absence of a diagnosis does not make supportive counseling or practical help inappropriate. Clinical care works best when goals and expected benefits are discussed openly.
Grief Screening in Research and Public Health
Research surveys can estimate the proportion of people reporting elevated grief symptoms. They also help identify groups that may need outreach, evaluate change, and compare instruments. But a study that defines probable PGD solely by crossing a self-report cutoff should describe that outcome accurately. It should not automatically report a prevalence of confirmed clinical diagnoses.
In their review of PGD classification practices, Stroebe, Schut, and Eisma found that studies frequently presented self-report thresholds as if they established diagnostic status. They recommend clearer reporting, including the exact criteria and instruments used and whether clinical interviews confirmed cases. For readers, the crucial question is: does the number represent elevated symptoms, probable cases, or clinician-established diagnoses?
A Practical Checklist for Understanding Any Grief Questionnaire
Before interpreting an online or clinical screen, identify its exact name and version, the intended age range, the diagnostic framework or grief construct it measures, its recall period, the validated language and population, the meaning and limitations of its cutoff, and whether it was administered with a trained clinician. Ask whether distress, impairment, duration, and cultural context were evaluated separately and whether further assessment is planned.
If the questionnaire or service cannot answer those questions, treat its result as an informal prompt for conversation rather than as evidence of a particular diagnosis. A well-designed assessment respects the person's own experience as well as the evidence behind the measure.
Frequently Asked Questions
Can a grief screening questionnaire diagnose prolonged grief disorder?
No. A questionnaire can indicate symptom severity or probable PGD according to specified scoring rules. A diagnosis requires a clinical evaluation of the applicable criteria, the death and timeline, clinically significant distress or impairment, cultural context, and other conditions. Research guidelines explicitly advise against equating questionnaire cutoffs with confirmed cases.
Is there a single official test for prolonged grief disorder?
There are validated and emerging measures, including the PG-13-R, TGI-SR+, IPGDS, and Aarhus instruments. There is no one questionnaire that universally replaces clinical assessment for every age, language, setting, or diagnostic system. The right instrument depends on the assessment purpose.
Can I take a prolonged grief test online?
You can complete a reputable self-report measure as a way to reflect on symptoms. Check its source and interpretation before relying on it. A result from an online tool should be discussed with a qualified clinician when distress or impairment is substantial.
What is the difference between PG-13 and PG-13-R?
They are related but distinct versions developed in the evolution of PGD measurement. The PG-13-R was designed to map to DSM-5-TR PGD criteria. Scoring and diagnostic claims should use research appropriate to the actual version, not an interchangeable label.
How long after a death can PGD be diagnosed?
Under DSM-5-TR, at least 12 months must have elapsed for adults and six months for children and adolescents. ICD-11 describes a minimum period of more than six months alongside culturally contextualized diagnostic requirements. Neither duration alone is sufficient for diagnosis.
Can a person have grief and depression at the same time?
Yes. Grief and major depressive disorder may overlap or coexist, and a clinician examines each pattern and its effects rather than assuming one excludes the other. A grief scale is not a complete depression assessment.
Does a high grief score mean my grieving is abnormal?
A high score indicates stronger endorsement of the questionnaire's items. It does not measure whether your emotions are acceptable, whether you loved someone too much, or whether you have a disorder. The interpretation depends on context, functioning, criteria, and clinical evaluation.
Can the same questionnaire be used for teenagers and adults?
Only when there is suitable age-specific validation and the items are developmentally appropriate. Younger people may understand or express symptoms differently, and specialized youth instruments are being developed and studied. Age-specific clinical criteria must also be applied correctly.
What is a structured clinical interview?
It is an organized clinician-led assessment that follows standardized questions and decision rules. It helps clarify symptom patterns and consistency with diagnostic requirements. Interviews such as the Aarhus PGD Interview are designed for trained clinical use; a comprehensive evaluation also addresses context, comorbidity, and safety.
What if I am still grieving years later?
Grief can remain meaningful and emotionally intense over many years. Having memories, longing, or anniversary reactions does not by itself indicate a disorder. Consider an assessment if the grief is persistently overwhelming, significantly interferes with daily life, or raises concerns you want professional help with.
Do bereaved people have to go through five stages before assessment?
No. The stages model is familiar but does not prescribe a universal sequence of human grieving or function as a validated diagnostic instrument. Assessment focuses on the person's actual experiences, context, functioning, and needs.
What if grief includes thoughts of suicide?
Tell a clinician, trusted person, or crisis service directly, even if you have never completed a grief questionnaire. If you are in immediate danger, call local emergency services. In the United States, you can call or text 988 or use 988 Lifeline chat; elsewhere, contact your local crisis service. Safety assessment and support should happen promptly and do not depend on a PGD screening score.
Related Articles
References
American Psychiatric Association. (2024). DSM-5-TR Update, September 2024: Prolonged Grief Disorder differential diagnosis. Official APA update.
Killikelly, C., et al. (2020). Development of the International Prolonged Grief Disorder Scale for the ICD-11: Measurement of core symptoms and culture items adapted for Chinese and German-speaking samples. Journal of Affective Disorders, 277, 568–576. https://doi.org/10.1016/j.jad.2020.08.057.
Lenferink, L. I. M., et al. (2022). Valid measurement of DSM-5 persistent complex bereavement disorder and DSM-5-TR and ICD-11 prolonged grief disorder: The Traumatic Grief Inventory–Self Report Plus. Comprehensive Psychiatry, 112, 152281. https://doi.org/10.1016/j.comppsych.2021.152281.
O'Connor, M., et al. (2025). Development and validation of the Aarhus Structured Clinical Interview for Prolonged Grief Disorder in ICD-11 and DSM-5-TR (A-PGDi). European Journal of Psychotraumatology, 16, 2511373. https://doi.org/10.1080/20008066.2025.2511373.
Prigerson, H. G., et al. (2021). Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale. World Psychiatry, 20, 96–106. https://doi.org/10.1002/wps.20823.
Redican, E., Vang, M. L., & O'Connor, M. (2025). Development and validation of a brief Aarhus Prolonged Grief Disorder Scale. Death Studies. https://doi.org/10.1080/07481187.2025.2572746.
Stroebe, M. S., Schut, H. A. W., & Eisma, M. C. (2024). On the classification and reporting of prolonged grief: Assessment and research guidelines. Harvard Review of Psychiatry, 32, 15–32. https://doi.org/10.1097/HRP.0000000000000389.
Szuhany, K. L., Malgaroli, M., Miron, C. D., & Simon, N. M. (2021). Prolonged grief disorder: Course, diagnosis, assessment, and treatment. Focus, 19, 161–172. https://doi.org/10.1176/appi.focus.20200052.
Treml, J., Kaiser, J., Plexnies, A., & Kersting, A. (2020). Assessing prolonged grief disorder: A systematic review of assessment instruments. Journal of Affective Disorders, 274, 420–434. https://doi.org/10.1016/j.jad.2020.05.049.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official WHO publication.
Zhang, T., Krysinska, K., Alisic, E., & Andriessen, K. (2025). Grief instruments in children and adolescents: A systematic review. OMEGA—Journal of Death and Dying, 91, 2183–2225. https://doi.org/10.1177/00302228231171188.